Glucagon receptor antagonists, preparation and therapeutic uses

Details for Australian Patent Application No. 2006342449 (hide)

Owner Eli Lilly and Company

Inventors Zhu, Guoxin; Li, Jianke

Agent Spruson & Ferguson

Pub. Number AU-B-2006342449

PCT Pub. Number WO2007/123581

Priority 60/737,783 17.11.05 US

Filing date 14 November 2006

Wipo publication date 1 November 2007

Acceptance publication date 1 March 2012

International Classifications

C07C 233/83 (2006.01) Carboxylic acid amides

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/123581 Priority application(s): WO2007/123581

1 March 2012 Application Accepted

  Published as AU-B-2006342449

28 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006342459-Strand guide device

2006342447-Translational dysfunction based therapeutics